Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1996
12/27/1996CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
12/27/1996CA2179314A1 Esters and amides of 9(z)-retinoic acid
12/25/1996CN1138853A 1,5-benzodiazepine derivatives useful as CCK or gastrin antagonists
12/25/1996CN1138851A Metalloproteinase inhibitors
12/25/1996CN1138588A Phosphonomonoester nucleic acids, process for their preparation, and their use
12/25/1996CN1033638C Novel alpha-mannosidase and fucosidase inhibitors
12/24/1996US5587497 19-nor-vitamin D compounds
12/24/1996US5587493 Process for preparing taxoids
12/24/1996US5587459 Linked to a ligand targeting a cell surface receptor; for treating cancers and autoimmune diseases
12/24/1996US5587371 Effective for treating hypoxic areas of solid neoplasms
12/24/1996US5587306 Dna sequences
12/24/1996US5587289 Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof
12/24/1996US5587162 Administering to mammal a cytotoxin
12/24/1996US5587161 Prodrugs for antibody directed enzyme prodrug therapy
12/20/1996CA2179426A1 Use of ligands specific to rxr receptors
12/19/1996WO1996041191A1 Methods and uses for apoptin
12/19/1996WO1996040977A1 Origin of replication complex genes
12/19/1996WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA
12/19/1996WO1996040903A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996WO1996040898A1 Triple-helix forming oligonucleotides for targeted mutagenesis
12/19/1996WO1996040878A1 Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
12/19/1996WO1996040868A1 Essential oligonucleotides of vertebrate telomerase
12/19/1996WO1996040789A1 THERAPEUTIC COMPOUNDS COMPRISED OF ANTI-Fc RECEPTOR ANTIBODIES
12/19/1996WO1996040762A1 Monocyte chemotactic protein-4
12/19/1996WO1996040757A2 Lhrh antagonist peptides
12/19/1996WO1996040752A1 Novel dolastatin derivatives, their preparation and use
12/19/1996WO1996040751A1 Novel dolastatin derivatives, their preparation and use
12/19/1996WO1996040747A1 Urokinase receptor ligands
12/19/1996WO1996040745A2 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996WO1996040739A2 Urethane mediated, gst specific molecular release systems
12/19/1996WO1996040737A1 Reversible cysteine protease inhibitors
12/19/1996WO1996040728A2 Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds
12/19/1996WO1996040719A1 Endothelial-monocyte activating polypeptide iii
12/19/1996WO1996040711A1 Cross-linking oligonucleotides
12/19/1996WO1996040689A1 Cytotoxic macrolides
12/19/1996WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
12/19/1996WO1996040669A1 Retinoids and methods of use of same
12/19/1996WO1996040657A1 Inhibitors of phospholipase a¿2?
12/19/1996WO1996040648A1 Quinazolines and pharmaceutical compositions
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040620A1 Chalcone retinoids and methods of use of same
12/19/1996WO1996040293A1 Structurally determined metallo-constructs and applications
12/19/1996WO1996040291A1 Radiolabeled peptide compositions for site-specific targeting
12/19/1996WO1996040289A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
12/19/1996WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996WO1996040267A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996WO1996040253A2 Rna photocleavage using texaphyrins
12/19/1996WO1996040238A1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/19/1996WO1996040228A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996WO1996040227A1 Tumor associated epitopes
12/19/1996WO1996040211A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996WO1996040200A1 Method for treating tumors with a toxin
12/19/1996WO1996040184A1 New cryptophycins from synthesis
12/19/1996WO1996040173A1 Hapten modified tumor cell extract and methods of treating or screening for cancer
12/19/1996WO1996040166A1 Nucleotide analogues for topical treatment of proliferative disease of the skin
12/19/1996WO1996040165A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996WO1996040157A1 USE OF ANTISENSE OLIGONUCLEOTIDES TO IL-6 RECEPTOR mRNA TO INHIBIT CELLULAR PROLIFERATION
12/19/1996WO1996040154A1 Use of vitamin d4 derivatives for treating skin disorders
12/19/1996WO1996040153A1 Use of vitamin d4 derivatives for treating cancer
12/19/1996WO1996040150A1 Treatment and prevention of prostatic disease
12/19/1996WO1996040142A1 Heterocyclic ring-fused pyrimidine derivatives
12/19/1996WO1996040132A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040131A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040122A1 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia
12/19/1996WO1996040120A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
12/19/1996WO1996040119A1 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
12/19/1996WO1996040116A1 Indolinone compounds for the treatment of disease
12/19/1996WO1996040115A1 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
12/19/1996WO1996040108A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996WO1996040100A1 ARYLSULFONYLAMINOBENZENE DERIVATIVES AND THE USE THEREOF AS FACTOR Xa INHIBITORS
12/19/1996WO1996040056A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996WO1996040055A2 Biological agent compositions
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039841A1 Tumor- or cell-specific herpes simplex virus replication
12/19/1996WO1996039831A1 Prodrugs of pharmaceuticals with improved bioavailability
12/19/1996WO1996031237A3 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
12/19/1996CA2236946A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996CA2224191A1 Urethane mediated, gst specific molecular release systems
12/19/1996CA2224160A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996CA2224115A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224113A1 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
12/19/1996CA2224103A1 Method and compositions for inhibition of adaptor protein/tyrosine kinase interactions
12/19/1996CA2224099A1 Monocyte chemotactic protein-4
12/19/1996CA2224097A1 The regulation of systemic immune responses utilizing cytokines and antigens
12/19/1996CA2223993A1 Method for treating tumors with a toxin
12/19/1996CA2223967A1 Use of 1,2,4-triazole derivatives for the manufacture of a medicament for the treatment of cancers
12/19/1996CA2223948A1 Chalcone retinoids and methods of use of same
12/19/1996CA2223940A1 Macrophage activating factors derived from cloned vitamin d binding protein
12/19/1996CA2223878A1 Inhibitors of phospholipase a2
12/19/1996CA2223803A1 Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
12/19/1996CA2223737A1 Use of conotoxin peptides u002 and mii for treating or detecting small-cell lung carcinoma
12/19/1996CA2223727A1 Arylsulfonylaminobenzene derivatives and the use thereof as factor xa inhibitors
12/19/1996CA2223718A1 Retinoids and methods of use of same
12/19/1996CA2223640A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996CA2223584A1 Crosslinking oligonucleotides
12/19/1996CA2223435A1 Use of benzimidazoles for the manufacture of a medicament for the treatment of leukemia
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223109A1 Use of antisense oligonucleotides to il-6 receptor mrna to inhibit cellular proliferation
1 ... 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 ... 2211